Paul Brown > Hogan Lovells International LLP > London, England > Lawyer Profile
Hogan Lovells International LLP Offices
ATLANTIC HOUSE
HOLBORN VIADUCT
LONDON
EC1A 2FG
England
- Firm Profile
- Go to...
Paul Brown
Work Department
Intellectual Property: Patent Litigation (London (Firms)
Position
Partner
Career
Paul Brown’s primary focus is on patents in the electronics and medical devices sector. His practice is multi-jurisdictional and predominantly litigious, although he also advises clients in relation to licensing and strategic planning. In the electronics sector, Paul advises a variety of clients on both assertion of patents and defense against infringement claims in disputes concerning essential and non-essential technologies and is dubbed the ‘mobile phones expert’ by Legal 500, 2015.
In conjunction with the Hogan Lovells Competition Law practice, Paul also advises clients on the overlap between competition law and IP, including on issues such as the availability of injunctions on essential patents and other aspects of FRAND obligations. In the medical device sector, Paul has represented clients in cases relating to coronary stents and also septal defect occlusion devices
Languages
English
Memberships
Member, Chartered Institute of Patent Attorneys
Member, AIPPI
Education
LL.M., University College London 2000
LL.B., University College London 1999
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
(Leading individuals)The ‘amazing’ Hogan Lovells International LLP maintains a strong practice in pan-European patent litigation strategy alongside a strong transactional practice. The team is helmed ‘force of nature’ Paul Brown, who is sought out by clients for his expertise in patent-related disputes in the electronics and medical devices sector. ‘Superb’ Stephen Bennett
is also in high demand with pharma companies for his considerable experience in handling disputes. Another notable name is Joel Smith, who has strengths in both contentious and non-contentious matters, with a niche expertise in plant variety protection and regulation. Patent litigator Daniel Brook routinely undertakes cross-border pharma litigation, notably representing Eli Lilly in a dispute regarding its cancer drug pemetrexed. Katie McConnell is noted for her expertise in the telecoms and pharma fields, while Stella Wong focuses on medical device, pharmaceutical and biotechnology patents, balancing her legal practice with her work as a doctor. Counsels Emma Fulton and Dominic Hoar are also recommended.
Lawyer Rankings
- Intellectual property: patents (contentious and non-contentious) London > TMT (technology, media and telecoms)
- Leading individuals London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
Top Tier Firm Rankings
- Public sector > Administrative and public law
- Dispute resolution > Banking litigation: investment and retail
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: premium
- Real estate > Commercial property: corporate occupiers
- Real estate > Commercial property: development
- Risk advisory > Data protection, privacy and cybersecurity
- TMT (technology, media and telecoms) > Fintech
- Crime, fraud and licensing > Fraud: civil
- Projects, energy and natural resources > Infrastructure: Project finance and development
- Insurance > Insurance: corporate and regulatory
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Industry focus > Emerging markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Investment fund formation and management > Listed funds
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Insurance > Product liability: defendant
- Real estate > Property litigation
- Finance > Trade finance
Firm Rankings
- Real estate > Commercial property: investment
- Dispute resolution > Competition litigation
- Real estate > Construction: contentious
- Real estate > Construction: non-contentious
- Risk advisory > Corporate governance
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Finance > Derivatives and structured products
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Industry focus > Hospitality and leisure
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Dispute resolution > International arbitration
- Projects, energy and natural resources > Oil and gas
- Insurance > Professional negligence
- Real estate > Property finance
- Investment fund formation and management > Real estate funds
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Securitisation
- Finance > Transport finance and leasing
- Finance > Acquisition finance
- Transport > Aviation
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Employment > Employee share schemes
- Corporate and commercial > Equity capital markets – mid-large cap
- Corporate and commercial > EU and competition: trade, WTO anti-dumping and customs
- Corporate and commercial > Financial services: non-contentious/regulatory
- Employment > Health and safety
- Finance > High yield
- Insurance > Insurance and reinsurance litigation
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Projects, energy and natural resources > Mining and minerals
- Real estate > Planning
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- Dispute resolution > Public international law
- Transport > Rail
- Dispute resolution > Tax litigation and investigations
- Corporate and commercial > VAT and indirect tax
- Projects, energy and natural resources > Water
- Investment fund formation and management > Fund finance
- Projects, energy and natural resources > Power (including electricity, nuclear and renewables)
- Investment fund formation and management > Private funds
- Employment > Employers
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- TMT (technology, media and telecoms) > Sport
- Corporate and commercial > Equity capital markets – small-mid cap
- Insurance > Insurance litigation: for policyholders